MAPT and neurodegenerative disease: Overall, given the limitations linked to conventional immunotherapy in neurodegenerative diseases, this work demonstrates the efficacy and the advantages of using intramuscular injection of vectorized scFv to target tau, and its relevant translational features, suggesting potential applications to other brain proteinopathies.